Related Experiment Video
Updated: Mar 15, 2026
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.6K
Current status in cancer cell reprogramming and its clinical implications
Kenan Izgi1,2, Halit Canatan3,2, Banu Iskender4,5
1Department of Medical Biochemistry, Faculty of Medicine, Erciyes University, 38039, Melikgazi, Kayseri, Turkey.
Journal of Cancer Research and Clinical Oncology
|September 14, 2016
Summary
Reprogramming cancer cells into induced pluripotent stem cells (iPSCs) offers a novel approach to study early cancer development and heterogeneity. This technology aids in understanding cancer epigenetics and developing targeted therapies.
Area of Science:
- Cell Biology
- Cancer Research
- Stem Cell Technology
Background:
- Reprogramming terminally differentiated cells to an embryonic-like state is possible.
- Induced pluripotent stem cell (iPSC) technology offers a novel model for early cancer stages.
- Current cancer models have limitations in reflecting tumor heterogeneity and late-stage markers.
Purpose of the Study:
- To explore the potential of reprogramming malignant cells into a stem cell-like state.
- To establish iPSC technology as an alternative model for recapitulating early cancer stages.
- To provide a tool for understanding tumor initiation, progression, heterogeneity, and cancer stem cell origins.
Main Methods:
- Review of recent findings on cancer cell reprogramming.
- Emphasis on similarities between cancer cells and pluripotent cells.
- Discussion of challenges in cancer cell reprogramming, including epigenetic states and chromosomal aberrations.
Main Results:
- Cancer epigenetics is a significant hurdle for using cancer iPSCs as models and for biomarker research.
- Optimizing cancer cell reprogramming may identify cancer-specific epigenetic states.
- Reprogramming could revert malignant phenotypes to a manageable state.
Conclusions:
- Reprogramming cancer cells enhances understanding of the cancer-specific epigenome.
- Elucidates overlapping mechanisms between cancer-initiating cells and pluripotent cells.
- Provides a platform for cancer type-specific drug discovery.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
02:40Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
02:40Cancer Stem Cells and Tumor Maintenance
2.3K
2.3K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
01:14Introduction to Nuclear Reprogramming
2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K